Natalie Notkin
Quark Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Chronic Obstructive Pulmonary Disease (COPD) Research, Angiogenesis and VEGF in Cancer, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Genomics, phytochemicals, and oxidative stress
Most-Cited Works
- → Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke–induced pulmonary injury and emphysema(2010)238 cited
- RTP801i: A Novel Anti–Angiogenic Strategy Superior to and Cooperative With VEGF–A Blockade in Suppressing CNV(2006)